20 May 2013
Keywords: andrx, exit, brand-drug, business, drugmaker, says, its
Article | 10 January 2005
US drugmaker Andrx says that its board of directors has approved a realignment plan that will focus on its core ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
© 2013 thepharmaletter.com